^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

TRAK2 (Trafficking Kinesin Protein 2)

i
Other names: TRAK2, Trafficking Kinesin Protein 2, KIAA0549, ALS2CR3, CALS-C, GRIF-1, OIP98, MILT2, Amyotrophic Lateral Sclerosis 2 Chromosomal Region Candidate Gene 3 Protein, Amyotrophic Lateral Sclerosis 2 (Juvenile) Chromosome Region, Candidate 3, O-Linked N-Acetylglucosamine Transferase Interacting Protein 98, Gamma-Aminobutyric Acid(A) Receptor-Interacting Factor, Trafficking Protein, Kinesin Binding 2, Trafficking Kinesin-Binding Protein 2, Milton Homolog 2 (Drosophila), Milton Homolog 2, GRIF1
Associations
Trials
9ms
CircSLC22A3 inhibits the invasion and metastasis of ESCC via the miR-19b-3p/TRAK2 axis and by reducing the stability of m6A-modified ACSBG1 mRNA. (PubMed, BMC Cancer)
The present study identified circSLC22A3 as a new tumor suppressor that inhibited ESCC progression through both the circSLC22A3/ miR-19b-3p/ TRAK2 and circSLC22A3/ IGF2BP1/ ACSBG1 axes.
Journal
|
IGF2BP1 (Insulin Like Growth Factor 2 MRNA Binding Protein 1) • MIR19B1 (MicroRNA 19b-1) • SLC22A3 (Solute Carrier Family 22 Member 3) • TRAK2 (Trafficking Kinesin Protein 2)
|
dactinomycin
12ms
Journal
|
PPL (Periplakin) • MITF (Melanocyte Inducing Transcription Factor) • EPM2A (EPM2A Glucan Phosphatase) • LINC00518 (Long Intergenic Non-Protein Coding RNA 518) • TRAK2 (Trafficking Kinesin Protein 2)
almost3years
Identifying mRNAs Residing in Myelinating Oligodendrocyte Processes as a Basis for Understanding Internode Autonomy. (PubMed, Life (Basel))
Complementary in situ hybridization (ISH) is recommended to confirm residences of mRNAs in MSAS. As both proteins and lipids are synthesized in MSAS, understanding myelination should not only include efforts to identify proteins synthesized in MSAS, but also the lipids.
Journal
|
TRAK2 (Trafficking Kinesin Protein 2)
|
TP53 expression
almost3years
Gamma-Aminobutyric Acid Type A Receptor Subunit Pi is a potential chemoresistance regulator in colorectal cancer. (PubMed, Mol Biol Rep)
We identify GABRP as a promising drug target to mediate oxaliplatin or 5-FU resistance in CRC. It provided the theoretical basis and potential clinical value for CRC patients.
Journal
|
GABARAP (GABA Type A Receptor-Associated Protein) • ANKRD66 (Ankyrin Repeat Domain 66) • CLINT1 (Clathrin Interactor 1) • GABARAPL1 (GABA Type A Receptor Associated Protein Like 1) • GABARAPL2 (GABA Type A Receptor Associated Protein Like 2) • GABRP (Gamma-Aminobutyric Acid Type A Receptor Subunit Pi) • TRAK2 (Trafficking Kinesin Protein 2)
|
5-fluorouracil • oxaliplatin